USPTO serial 79412460
CRYOSTEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2026
- Examiner
- KERTGATE, AMY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CRYOSTEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bruce S. Londa
Bruce S. Londa Norris McLaughlin, P.A.7 Times Square21st FloorNew York, NY 10036Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 038 | Providing online discussion forums in the field of health by means of a telecommunication network and on the Internet; all the aforementioned services being exclusively related to allogeneic hematopoietic stem cell transplantation and cellular therapies in hematology | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, seminars, workshops in the field of health hematology and cell therapies; Training services in the field of health, hematology and cell therapies; Educational services, namely, organizing and conducting of colloquiums, seminars, conferences and congresses in the field of health, hematology and cell therapies; Educational services, namely, organizing and providing of in-person discussion forums in the field of health, on a telecommunications network and on the Internet; Organization of exhibitions for cultural or educational purposes; Editing and publication of printed matter in the nature of books, magazines and texts; Online electronic publishing of texts, other than advertising texts; Editing of printed matter, radio and television programs, photos, videos, sounds and images intended for the public; Editing and publishing of written texts, other than advertising texts, on a telecommunications network; online editing of publications; Publication of scientific articles; Publication of scientific articles in the fields of hematology and cell therapies; Publication of scientific articles in the fields of hematopoietic stem cell allograft or bone marrow allograft and post- hematopoietic stem cell or bone marrow allograft complications; Publication of scientific articles featuring results from scientific projects using biological resources from a standardized collection of biological samples in the fields of hematopoietic stem cell allograft or bone marrow allograft and post-hematopoietic stem cell or bone marrow allograft complications; Publication of information bulletins being newsletters in the field of health, hematology and cell therapies; Publication of posters; all the aforementioned services being exclusively related to allogeneic hematopoietic stem cell transplantation and cellular therapies in hematology | ACTIVE | — |
| 042 | Scientific research services for medical purposes; Scientific analysis services in the field of health exclusively related to hematology and cell therapies; Medical and scientific research, namely, conducting clinical trials for others; Research and development of scientific programs in the field of hematopoietic stem cell transplantation (HSCT) and transplantation-related complications; Biological and medical research; Clinical research in the field of hematopoietic stem cell transplantation (HSCT) and transplantation-related complications; Scientific research in the fields of hematology and cell therapies; Scientific research on hematopoietic stem cell allograft and bone marrow allograft complications; Providing medical and scientific research information in the field of clinical trials; Design and operation of a scientific database being database design and development; Laboratory services, namely, preparation of biological samples for research purposes; Laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; Laboratory services, namely, preparation of biological samples in the fields of hematology and cell therapies for research purposes; Laboratory services, namely, preparation of biological samples dedicated to hematopoietic stem cell allograft complications for research purposes; Creation of standardized scientific databases for collections of biological samples in the fields of hematology and cell therapies for research purposes; Operation of standardized scientific databases for collections of biological samples, namely, providing an online standardized scientific database comprised of collected biological samples in the fields of hematology and cell therapies for research purposes; all the aforementioned services being exclusively related to allogeneic hematopoietic stem cell transplantation and cellular therapies in hematology | ACTIVE | — |
| 044 | Medical services; Medical assistance; Hospital services; services provided by doctors and medical personnel specialized in the field of transplants, namely, cultured cell bank services for medical transplantation; Cell collection and analysis services being medical services relating to the removal, treatment and processing of human cells; Medical treatment using a standardized collection of biological samples in the nature of cultured cells dedicated to complications of hematopoietic stem cell allografts from allograft donor-recipient pairs; Medical laboratory services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories featuring the analysis of biological samples taken from patients; Preparation of reports being medical reporting services with respect to health care; Preparation and compilation of medical reports being medical reporting services; Provision of medical information; all the aforementioned services being exclusively related to allogeneic hematopoietic stem cell transplantation and cellular therapies in hematology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Association CRYOSTEM
- Other trademarks owned by Association CRYOSTEM
- Other trademarks owned by Association CRYOSTEM
- Other trademarks in Class 038
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CRYOSTEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 23, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 23, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 5, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 9, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 7, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |